NIH-funded research NIH-funded research

Affordable detection of drug-resistant Pseudomonas in eyedrops and local samples

Official title: Surveillance of drug-resistant bacteria in resource-limited settings: a focus on cost-effective long-read sequencing of eyedrop-associated P. aeruginosa and locally sourced metagenomic samples

Funded at California State University Fresno · NIH-11181158 · Data updated 2026-11-12

This project tests low-cost DNA sequencing to find drug-resistant Pseudomonas in contaminated eyedrops and nearby environmental samples for communities with limited lab resources.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCalifornia State University Fresno
NIH-funded
Lab location1 site (Fresno, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2028
Funding year2025
Award (this year)$175,000
NIH project number5R16AI184350-02
Project IDNIH-11181158 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are people, clinics, or community sites that have used preservative-free eyedrops or are in areas where contaminated products or local bacterial infections are suspected.

Less likely to help

People without exposure to eyedrops or those needing immediate individual medical treatment are unlikely to get direct clinical benefit from this surveillance project.

What this research studies

If I'm worried about contaminated preservative-free eyedrops or local infections, this project will set up affordable long-read DNA sequencing at community sites to look for drug-resistant Pseudomonas and related bacteriophages. The team will use compact Flongle sequencers that can run small assays for under $100 per run to assemble bacterial and phage genomes from eyedrop-associated and locally sourced metagenomic samples. The approach is a pilot of a decentralized surveillance system aimed at resource-limited settings so tests can be done quickly and cheaply near where people live. Results would help local health workers spot outbreaks sooner and guide safer product handling and infection control.

Why it matters

Potential benefit: If successful, this could enable faster, cheaper detection of antibiotic-resistant bacteria in eyedrops and local environments, improving outbreak response and product safety in underserved areas.

How similar studies have gone: Long-read nanopore sequencing has been used to track outbreaks and assemble bacterial genomes before, but using very low-cost Flongle runs for decentralized surveillance of eyedrop contamination is a relatively new application.

Where this research is happening

  • California State University Fresno
    Fresno, United States
    Active

Researchers

  • Principal investigator: Shim, Hyunjin — California State University Fresno
  • Study coordinator: Shim, Hyunjin

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.